Authors:
Rummukainen, JK
Salminen, T
Lundin, J
Kytola, S
Joensuu, H
Isola, JJ
Citation: Jk. Rummukainen et al., Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array, MOD PATHOL, 14(10), 2001, pp. 1030-1035
Authors:
Lundin, J
Lundin, M
Holli, K
Kataja, V
Elomaa, L
Pylkkanen, L
Turpeenniemi-Hujanen, T
Joensuu, H
Citation: J. Lundin et al., Omission of histologic grading from clinical decision making may result inoveruse of adjuvant therapies in breast cancer: Results from a nationwide study, J CL ONCOL, 19(1), 2001, pp. 28-36
Authors:
Leivonen, M
Nordling, S
Lundin, J
von Boguslawski, K
Haglund, C
Citation: M. Leivonen et al., p27 expression correlates with short-term, but not with long-term prognosis in breast cancer, BREAST CANC, 67(1), 2001, pp. 15-22
Authors:
Sjostrom, J
Alfthan, H
Joensuu, H
Stenman, UH
Lundin, J
Blomqvist, C
Citation: J. Sjostrom et al., Serum tumour markers CA 15-3, TPA, TPS, hCG beta and TATI in the monitoring of chemotherapy response in metastatic breast cancer, SC J CL INV, 61(6), 2001, pp. 431-441
Authors:
Rummukainen, JK
Salminen, T
Lundin, J
Joensuu, H
Isola, JJ
Citation: Jk. Rummukainen et al., Amplification of c-myc oncogene by chromogenic and fluorescence in situ hybridization in archival breast cancer tissue array samples, LAB INV, 81(11), 2001, pp. 1545-1551
Authors:
Wiksten, JP
Lundin, J
Nordling, S
Lundin, M
Kokkola, A
von Bocuslawski, K
Haglund, C
Citation: Jp. Wiksten et al., Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer, INT J CANC, 95(1), 2001, pp. 1-6
Authors:
Lundin, M
Nordling, S
Lundin, J
Alfthan, H
Stenman, UH
Haglund, C
Citation: M. Lundin et al., Tissue expression of human chorionic gonadotropin beta predicts outcome incolorectal cancer: A comparison with serum expression, INT J CANC, 95(1), 2001, pp. 18-22
Authors:
Lundin, J
Kimby, E
Bergmann, L
Karakas, T
Mellstedt, H
Osterborg, A
Citation: J. Lundin et al., Interleukin 4 therapy for patients with chronic lymphocytic leukaemia: a phase I/II study, BR J HAEM, 112(1), 2001, pp. 155-160
Authors:
Hassan, M
Nilsson, C
Olsson, H
Lundin, J
Osterborg, A
Citation: M. Hassan et al., The influence of interferon-alpha on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite in patients with multiple myeloma, EUR J HAEMA, 63(3), 1999, pp. 163-170
Authors:
Lundin, M
Nordling, S
Roberts, PJ
Lundin, J
Carpelan-Holmstrom, M
von Boguslawsky, K
Haglund, C
Citation: M. Lundin et al., Sialyl Tn is a frequently expressed antigen in colorectal cancer: No correlation with patient prognosis, ONCOL-BASEL, 57(1), 1999, pp. 70-76
Authors:
Hedstrom, J
Grenman, R
Ramsay, H
Finne, P
Lundin, J
Haglund, C
Alfthan, H
Stenman, UH
Citation: J. Hedstrom et al., Concentration of free hCG beta subunit in serum as a prognostic marker forsquamous-cell carcinoma of the oral cavity and oropharynx, INT J CANC, 84(5), 1999, pp. 525-528
Authors:
Poikonen, P
Saarto, T
Lundin, J
Joensuu, H
Blomqvist, C
Citation: P. Poikonen et al., Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF, BR J CANC, 80(11), 1999, pp. 1763-1766